ME Therapeutics Holdings Inc.
METX
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.56% | -12.67% | -17.80% | -10.29% | 46.30% |
| Total Receivables | -28.91% | -23.99% | 102.45% | 44.97% | -11.05% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 241.88% | -29.20% | -1.31% | -45.73% | -29.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.94% | -13.53% | -15.23% | -10.67% | 40.75% |
|
|
|||||
| Total Current Assets | -24.94% | -13.53% | -15.23% | -10.67% | 40.75% |
| Net Property, Plant & Equipment | 3.03% | -11.59% | 8.07% | -2.41% | 113.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.56% | -1.27% | 0.00% | 5.33% | -3.85% |
| Total Assets | -20.76% | -13.18% | -12.51% | -9.74% | 45.64% |
|
|
|||||
| Total Accounts Payable | -34.57% | -16.55% | 239.34% | 484.21% | -91.15% |
| Total Accrued Expenses | 2.50% | 12.15% | -44.27% | -28.62% | 17.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.33% | -7.22% | 4.73% | 9.59% | 1.31% |
| Total Finance Division Other Current Liabilities | 2.86% | -1.87% | 0.00% | -- | -- |
| Total Other Current Liabilities | 2.86% | -1.87% | 0.00% | -- | -- |
| Total Current Liabilities | -26.60% | -11.59% | 69.29% | 47.97% | -43.14% |
|
|
|||||
| Total Current Liabilities | -26.60% | -11.59% | 69.29% | 47.97% | -43.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -59.69% | -33.33% | -28.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -26.60% | -15.34% | 49.08% | 24.23% | -39.48% |
|
|
|||||
| Common Stock & APIC | 2.45% | 2.10% | 0.13% | 4.91% | 36.45% |
| Retained Earnings | -5.41% | -1.28% | -3.74% | -9.01% | 0.72% |
| Treasury Stock & Other | 2.45% | -9.41% | 0.13% | 4.91% | -36.70% |
| Total Common Equity | -19.78% | -12.81% | -18.27% | -11.99% | 60.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.78% | -12.81% | -18.27% | -11.99% | 60.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.78% | -12.81% | -18.27% | -11.99% | 60.60% |
|
|
|||||